Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Operating Expenses (2018 - 2025)

Dna X's Operating Expenses history spans 8 years, with the latest figure at -$15.7 million for Q4 2025.

  • Quarterly results put Operating Expenses at -$15.7 million for Q4 2025, up 15.43% from a year ago — trailing twelve months through Dec 2025 was $5.4 million (up 74.39% YoY), and the annual figure for FY2025 was $5.4 million, up 74.39%.
  • Operating Expenses for Q4 2025 was -$15.7 million at Dna X, down from $5.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $12.5 million in Q3 2021 to a low of -$18.5 million in Q4 2024.
  • The 5-year median for Operating Expenses is $6.5 million (2023), against an average of $4.9 million.
  • Peak annual rise in Operating Expenses hit 156.56% in 2024, while the deepest fall reached 390.79% in 2024.
  • Year by year, Operating Expenses stood at $11.3 million in 2021, then tumbled by 55.66% to $5.0 million in 2022, then rose by 27.73% to $6.4 million in 2023, then crashed by 390.79% to -$18.5 million in 2024, then grew by 15.43% to -$15.7 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at -$15.7 million, $5.8 million, and $7.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.